title: Tenofovir treatment in patients with lamivudine-resistant hepatitis B mutants strongly affects viral replication.
authors.forename: Florian
authors.initials: F
authors.lastname: van Bömmel
authors.forename: Thomas
authors.initials: T
authors.lastname: Wünsche
authors.forename: Dirk
authors.initials: D
authors.lastname: Schürmann
authors.forename: Thomas
authors.initials: T
authors.lastname: Berg
mesh_terms: D000225:Adenine / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D024882:Drug Resistance, Viral; D006509:Hepatitis B / Q000188:drug therapy* / Q000821:virology; D006515:Hepatitis B virus / Q000187:drug effects* / Q000235:genetics / Q000254:growth & development; D006801:Humans; D019259:Lamivudine; D009154:Mutation; D063065:Organophosphonates; D009943:Organophosphorus Compounds / Q000627:therapeutic use*; D018894:Reverse Transcriptase Inhibitors / Q000627:therapeutic use*; D000068698:Tenofovir; D014779:Virus Replication / Q000187:drug effects
chemical_list: D063065:Organophosphonates; D009943:Organophosphorus Compounds; D018894:Reverse Transcriptase Inhibitors; D019259:Lamivudine; D000068698:Tenofovir; D000225:Adenine